Idiopathic multicentric Castleman disease with arteriolar endotheliopathy and secondary haemophagocytosis
Lancet Haematol
.
2022 Jul;9(7):e546.
doi: 10.1016/S2352-3026(22)00037-0.
Authors
Christine M Campbell
1
,
Daniel R Owen
2
,
Amanallah Montazeripouragha
1
,
Iain McCormick
1
,
David C Fajgenbaum
3
,
Luke Y C Chen
4
Affiliations
1
Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
2
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
3
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
4
Department of Medicine, University of British Columbia, Vancouver, BC, Canada. Electronic address: lchen2@bccancer.bc.ca.
PMID:
35772433
PMCID:
PMC9624448
DOI:
10.1016/S2352-3026(22)00037-0
No abstract available
MeSH terms
Castleman Disease* / complications
Humans
Lymphohistiocytosis, Hemophagocytic* / complications
Lymphohistiocytosis, Hemophagocytic* / diagnosis
Supplementary concepts
Multi-centric Castleman's Disease
Grants and funding
R01 HL141408/HL/NHLBI NIH HHS/United States